Further, we also verified that the expression of GRID2, PADI4, RIPK2, CUL4B, BCL6, MRPS31, GPI, and MAP 2 K1 were both significantly increased, and levels of MAPK, ELAVL1, RAB14, KLF9, ARF1, ARFGAP1, ATG7, ABCA7, SFT2D2, E2F2, MAPK7, and UHRF1 were both significantly decreased in PD. The gene discussed is MRPS31; the disease is Parkinson disease.